Recerca

Leucèmia i hemopaties pediàtriques

Buscador de publicacions

Publicacions

  • Gálvez E, Vallespín E, Arias-Salgado EG, Sánchez-Valdepeñas C, Giménez Y, Navarro S, Río P, Bogliolo M, Pujol R, Peiró M, Nevado J, Zubicaray J, Sebastián E, Català-Temprano A, Beléndez C, Díaz de Heredia C, Galera A, Badell I, Madero L, Perona R, Sastre L, Surrallés J, Bueren J, Lapunzina P and Sevilla J.

    Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias: Experience of the Spanish Network on Bone Marrow Failure Syndromes.

    hemasphere . 5(4): . Nº de cites: 7

    [doi:10.1097/HS9.0000000000000539]

  • Berrueco R, Sebastián E, Solsona M, González de Pablo J, Ruiz-Llobet A, Mesegue-Meda M, Gálvez E and Sevilla J.

    Secondary immune thrombocytopenia in children: Characteristics and outcome of a large cohort from two Spanish centres

    ACTA PAEDIATRICA . 110(6): 1952-1958. Nº de cites: 2

    [doi:10.1111/apa.15765]

  • Vega-García N, Pérez-Jaume S, Esperanza-Cebollada E, Vicente-Garces C, Torrebadell-Burriel M, Jiménez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sánchez-Garcia J, García-Calderon CB, Gómez-Casares MT, Martín-Clavero E, Escudero A, Riñón M, Muñoz L, Velasco MR, García-Morín M, Català-Temprano A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molinés A, Guerra-Garcia P, Pérez-Martínez A, García-Abós M, Robles R, Pisa S, Adán R, Díaz de Heredia C, Dapena JL, Rives-Solà S, Ramirez M and Camós-Guijosa M.

    Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.

    Frontiers in pediatrics . 8: 614521-614521. Nº de cites: 3

    [doi:10.3389/fped.2020.614521]

  • Ortíz-Maldonado V, Rives-Solà S, Castellà M, Alonso-Saladrigues A, Benítez-Ribas D, Caballero-Baños M, Baumann T, Jordi Cid Colom, Garcia-Rey E, Llanos C, Torrebadell-Burriel M, Villamor N, Giné E, Díaz-Beyá M, Guardia L, Montoro M, Català-Temprano A, Faura A, González EA, Español-Rego M, Klein-González N, Alsina L, Castro P, Jordán-García I, Fernández S, Ramos F, Suñé G, Perpiñá U, Canals JM, Lozano M, Trias E, Scalise A, Varea S, Sáez-Peñataro J, Torres F, Calvo G, Esteve J, Urbano-Ispizua Á, Juan-Otero M and Delgado J.

    CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+Relapsed/Refractory Malignancies

    MOLECULAR THERAPY . 29(2): 636-644. Nº de cites: 68

    [doi:10.1016/j.ymthe.2020.09.027]

  • Rössler J, Baselga E, Davila V, Celis-Passini V, Diociaiuti A, El Hachem M, Mestre S, Haeberli D, Prokop A, Hanke C, Loichinger W, Quéré I, Baumgartner I, Niemeyer CM and Kapp FG.

    Severe adverse events during sirolimus "off-label" therapy for vascular anomalies

    PEDIATRIC BLOOD & CANCER . 68(8): . Nº de cites: 25

    [doi:10.1002/pbc.28936]

  • Buechner J, Grupp SA, Hiramatsu H, Teachey DT, Rives-Solà S, Laetsch TW, Yanik GA, Wood P, Awasthi R, Yi L, Chassot-Agostinho A, Eldjerou LK and De Moerloose B.

    Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy.

    blood advances . 5(2): 593-601. Nº de cites: 21

    [doi:10.1182/bloodadvances.2020002757]

  • Cruz-Martínez O, Caloretti V, Salvador-Hernandez H, Celis-Passini V, Santa-María López V, Morales-La Madrid A, Suñol M, Puerta P, Muchart-Lopez J, Krauel L and Lavarino C.

    Synchronous choroid plexus papilloma and Wilms tumor in a girl, disclosing a Li-Fraumeni syndrome

    HEREDITARY CANCER IN CLINICAL PRACTICE . 19(1): 1-1.

    [doi:10.1186/s13053-020-00158-7]

  • Levine JE, Grupp SA, Pulsipher MA, Dietz AC, Rives-Solà S, Myers GD, August KJ, Verneris MR, Buechner J, Laetsch TW, Bittencourt H, Baruchel A, Boyer MW, De Moerloose B, Qayed M, Davies SM, Phillips CL, Driscoll TA, Bader P, Schlis K, Wood PA, Mody R, Yi L, Leung M, Eldjerou LK, June CH and Maude SL.

    Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia

    Journal for ImmunoTherapy of Cancer . 9(8): 2287. Nº de cites: 17

    [doi:10.1136/jitc-2020-002287]

  • Deyà-Martinez A, Alonso-Saladrigues A, Garcia, A. P., Faura, A., Torrebadell-Burriel M, Vlagea, A., Català-Temprano A, Esteve-Solé A, Juan-Otero M, Rives-Solà S and Alsina L.

    Kinetics of humoral deficiency in CART19-treated children and young adults with acute lymphoblastic leukaemia

    BONE MARROW TRANSPLANTATION . 56(2): 376-386. Nº de cites: 12

    [doi:10.1038/s41409-020-01027-6]

  • Torrents S, Alonso L, Vives J, Rodríguez L, Moron-Cazalilla G, Elorza-Alvarez I, Uria ML, Benitez MI, Parody R, Orti G, Trabazo M, Fernandez-Sojo J, Badell-Serra I and Querol S.

    Good Response Rates of WJ-MSC, Comparable to BMMSC, in the Treatment of Refractory GVHD

    BONE MARROW TRANSPLANTATION . 55(s1): 269-270.